[HTML][HTML] Biomedical Tools for STI Prevention and Management
JS Crowley, AB Geller, SH Vermund… - … a Sexual Health …, 2021 - ncbi.nlm.nih.gov
… of the public health agencies, as described in Chapter 2. … Serologic tests are most often
used for syphilis screening … decide to partner for moving promising candidates forward in …
used for syphilis screening … decide to partner for moving promising candidates forward in …
Chlamydia trachomatis vaccine development – a view on the current challenges and how to move forward
ÁH Borges, F Follmann, J Dietrich - Expert Review of Vaccines, 2022 - Taylor & Francis
… trachomatis serovars is conventionally based on serological … turn inward with progressing
fibrotic sequelae ultimately … trachomatis vaccine is thus a public health priority [Citation44…
fibrotic sequelae ultimately … trachomatis vaccine is thus a public health priority [Citation44…
[HTML][HTML] The performance of immunoassays to measure antibodies to the Chlamydia trachomatis antigen Pgp3 in different epidemiological settings for trachoma
…, M Haile, T Zeru, D Bethea, C Laurent… - The American Journal …, 2021 - ncbi.nlm.nih.gov
… that could be integrated with other public health programs. In this study, we evaluated
multiple tests to measure antibodies against the C. trachomatis antigen Pgp3—a multiplex bead …
multiple tests to measure antibodies against the C. trachomatis antigen Pgp3—a multiplex bead …
[HTML][HTML] Seroepidemiology of Chlamydia trachomatis Infection in the General Population of Northern China: The Jidong Community Cohort Study
J Shui, D Xie, J Zhao, C Ao, H Lin, Y Liang… - Frontiers in …, 2021 - frontiersin.org
… least one quarter of the people aged 18–65 years have been infected with C. … Chlamydia
trachomatis serological assay provides a tool to investigate the prevalence and incidence of C. …
trachomatis serological assay provides a tool to investigate the prevalence and incidence of C. …
Predicting future ocular Chlamydia trachomatis infection prevalence using serological, clinical, molecular, and geospatial data
C Tedijanto, S Aragie, Z Tadesse, M Haile, T Zeru… - medRxiv, 2021 - medrxiv.org
… used to guide control programs. However, … Chlamydia trachomatis (Ct), is a leading infectious
cause of blindness worldwide (1) and has been targeted for elimination as a public health …
cause of blindness worldwide (1) and has been targeted for elimination as a public health …
Advances in Chlamydia trachomatis Vaccination: Unveiling the Potential of Major Outer Membrane Protein Derivative Constructs
C Kiekens, SA Morré, D Vanrompay - Microorganisms, 2024 - mdpi.com
… , continues to be a significant public health concern. The majority of … women with tubal infertility
and serological evidence of C. … National control programs based on mass screening and …
and serological evidence of C. … National control programs based on mass screening and …
[HTML][HTML] Testing for sexually transmitted diseases in US public health laboratories, 2016
A Davis, A Gaynor - Sexually transmitted diseases, 2020 - journals.lww.com
… test (NAAT) for Chlamydia trachomatis (CT)/Neisseria … guidelines, the use of HSV serology
and culture is limited to … we found that PHLs were moving away from HSV culture and …
and culture is limited to … we found that PHLs were moving away from HSV culture and …
[HTML][HTML] Current and future trends in the laboratory diagnosis of sexually transmitted infections
G Caruso, A Giammanco, R Virruso… - … and Public Health, 2021 - mdpi.com
… This number included infections due to Chlamydia trachomatis … , serological assays for the
presence of serum antibodies … is one of the most promising applications of microfluidics [88]. …
presence of serum antibodies … is one of the most promising applications of microfluidics [88]. …
Evaluation of the performance of a point-of-care test for chlamydia and gonorrhea
… to advancing efforts to control the rates of chlamydial and … in rates of infection with Chlamydia
trachomatis and Neisseria … 92.5% will have both clinical and public health utility. The other …
trachomatis and Neisseria … 92.5% will have both clinical and public health utility. The other …
Chlamydia trachomatis, Pelvic Inflammatory Disease, and Epithelial Ovarian Cancer
J Paavonen, R Turzanski Fortner… - The Journal of …, 2021 - academic.oup.com
… increasing interest in the use of serologic methods and public health applications of such
methods. New serologic assays for C. … Advancing the public health applications of Chlamydia …
methods. New serologic assays for C. … Advancing the public health applications of Chlamydia …